The Seattle Cancer Care Alliance (SCCA), located in Seattle, Washington, is part of a dynamic collaboration among three organizations known nationally and internationally for their patient care and research: Fred Hutchinson Cancer Research Center, University of Washington, and Seattle Children's. Over the past 25 years, these institutions have worked together to support their mission of adult and pediatric oncology patient care services, research and education.
Immunotherapy is one of the greatest clinical care advancements of our time. We’ve known that ever since the pioneering work in bone marrow transplantation began more than 40 years ago. Right now, SCCA is changing the way cancer is prevented, treated and cured. Our doctors and nurses are leaders in this revolutionary field. Here, we offer a broader range of immunotherapy options for cancer patients. The promise of immunotherapy is boosting survival rates for patients with leukemia and other cancers. Our patients have access to a greater number of investigational immunotherapy treatments — using T cells, monoclonal antibodies and gene therapy—in clinical trials that are available at SCCA.
Our ground-breaking clinic supports cellular immunotherapy therapies and clinical trials. Our team consists of advanced practice providers, physicians, infusion nurses, clinical nurses coordinators, social worker, dietician, pharmacist, schedulers, research, and lab staff working together to support patients.